144 related articles for article (PubMed ID: 9920850)
1. Normal T-cell telomerase activity and upregulation in human immunodeficiency virus-1 infection.
Wolthers KC; Otto SA; Wisman GB; Fleury S; Reiss P; ten Kate RW; van der Zee AG; Miedema F
Blood; 1999 Feb; 93(3):1011-9. PubMed ID: 9920850
[TBL] [Abstract][Full Text] [Related]
2. Telomere length, telomerase activity, and replicative potential in HIV infection: analysis of CD4+ and CD8+ T cells from HIV-discordant monozygotic twins.
Palmer LD; Weng N; Levine BL; June CH; Lane HC; Hodes RJ
J Exp Med; 1997 Apr; 185(7):1381-6. PubMed ID: 9104824
[TBL] [Abstract][Full Text] [Related]
3. T cell telomere length in HIV-1 infection: no evidence for increased CD4+ T cell turnover.
Wolthers KC; Bea G; Wisman A; Otto SA; de Roda Husman AM; Schaft N; de Wolf F; Goudsmit J; Coutinho RA; van der Zee AG; Meyaard L; Miedema F
Science; 1996 Nov; 274(5292):1543-7. PubMed ID: 8929418
[TBL] [Abstract][Full Text] [Related]
4. L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine.
Moretti S; Famularo G; Marcellini S; Boschini A; Santini G; Trinchieri V; Lucci L; Alesse E; De Simone C
Antioxid Redox Signal; 2002 Jun; 4(3):391-403. PubMed ID: 12215207
[TBL] [Abstract][Full Text] [Related]
5. CD8+ lymphocyte responses to antiretroviral therapy of HIV infection.
Carr A; Emery S; Kelleher A; Law M; Cooper DA
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(4):320-6. PubMed ID: 8948369
[TBL] [Abstract][Full Text] [Related]
6. Genetic manipulation of telomerase in HIV-specific CD8+ T cells: enhanced antiviral functions accompany the increased proliferative potential and telomere length stabilization.
Dagarag M; Evazyan T; Rao N; Effros RB
J Immunol; 2004 Nov; 173(10):6303-11. PubMed ID: 15528369
[TBL] [Abstract][Full Text] [Related]
7. Normalization of CD4+ cell numbers and reduced levels of memory CD8+ cells in blood and tonsillar tissue after highly active antiretroviral therapy in early HIV type-1 infection.
Dyrhol-Riise AM; Voltersvik P; Røsok BI; Olofsson J; Asjö B
AIDS Res Hum Retroviruses; 2000 Feb; 16(3):191-201. PubMed ID: 10710207
[TBL] [Abstract][Full Text] [Related]
8. Increases in T cell telomere length in HIV infection after antiretroviral combination therapy for HIV-1 infection implicate distinct population dynamics in CD4+ and CD8+ T cells.
Kaushal S; Landay AL; Lederman MM; Connick E; Spritzler J; Kuritzkes DR; Kessler H; Levine BL; St Louis DC; June CH
Clin Immunol; 1999 Jul; 92(1):14-24. PubMed ID: 10413649
[TBL] [Abstract][Full Text] [Related]
9. Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age.
Son NH; Murray S; Yanovski J; Hodes RJ; Weng N
J Immunol; 2000 Aug; 165(3):1191-6. PubMed ID: 10903716
[TBL] [Abstract][Full Text] [Related]
10. Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy.
Bouscarat F; Levacher M; Landman R; Muffat-Joly M; Girard PM; Saimot AG; Brun-Vézinet F; Sinet M
AIDS; 1998 Jul; 12(11):1267-73. PubMed ID: 9708405
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of increased CD95 (APO-1/Fas) ligand in T cells from human immunodeficiency virus-type 1-infected children after antiretroviral therapy.
Böhler T; Herr I; Debatin KM; Geiss M; Haas J
Blood; 1997 Jul; 90(2):886-8. PubMed ID: 9226190
[No Abstract] [Full Text] [Related]
12. Reconstitution of human thymic implants is limited by human immunodeficiency virus breakthrough during antiretroviral therapy.
Amado RG; Jamieson BD; Cortado R; Cole SW; Zack JA
J Virol; 1999 Aug; 73(8):6361-9. PubMed ID: 10400728
[TBL] [Abstract][Full Text] [Related]
13. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.
Autran B; Carcelain G; Li TS; Blanc C; Mathez D; Tubiana R; Katlama C; Debré P; Leibowitch J
Science; 1997 Jul; 277(5322):112-6. PubMed ID: 9204894
[TBL] [Abstract][Full Text] [Related]
14. [Telomerase activity and telomere length in CD4+,CD8+ and CD19+ lymphocytes from patients with systemic lupus erythematosus].
Lin J; Xie J; Qian WB
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Nov; 34(6):534-7. PubMed ID: 16331816
[TBL] [Abstract][Full Text] [Related]
15. Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir.
Levacher M; Bouscarat F; Landman R; Chau F; Damond F; Gaudebout C; Mathez D; Leibowitch J; Saimot AG; Sinet M
AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1869-75. PubMed ID: 11118072
[TBL] [Abstract][Full Text] [Related]
16. A trial comparing nucleoside monotherapy with sequential therapy with 3 drugs in HIV-infected patients.
Roca B; Olmos P; Mínguez C; Arnedo A; Usó J; Teruel C; Segarra M; Sáez-Royuela A; Simón E
Scand J Infect Dis; 1998; 30(4):426-8. PubMed ID: 9817530
[TBL] [Abstract][Full Text] [Related]
17. Induction of telomerase activity and maintenance of telomere length in virus-specific effector and memory CD8+ T cells.
Hathcock KS; Kaech SM; Ahmed R; Hodes RJ
J Immunol; 2003 Jan; 170(1):147-52. PubMed ID: 12496394
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors.
Lichterfeld M; Mou D; Cung TD; Williams KL; Waring MT; Huang J; Pereyra F; Trocha A; Freeman GJ; Rosenberg ES; Walker BD; Yu XG
Blood; 2008 Nov; 112(9):3679-87. PubMed ID: 18728248
[TBL] [Abstract][Full Text] [Related]
19. T cell changes after combined nucleoside analogue therapy in HIV primary infection.
Carcelain G; Blanc C; Leibowitch J; Mariot P; Mathez D; Schneider V; Saimot AG; Damond F; Simon F; Debré P; Autran B; Girard PM
AIDS; 1999 Jun; 13(9):1077-81. PubMed ID: 10397538
[TBL] [Abstract][Full Text] [Related]
20. Accelerated replicative senescence of the peripheral immune system induced by HIV infection.
Bestilny LJ; Gill MJ; Mody CH; Riabowol KT
AIDS; 2000 May; 14(7):771-80. PubMed ID: 10839584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]